COLTENE Holding Past Earnings Performance

Past criteria checks 2/6

COLTENE Holding has been growing earnings at an average annual rate of 1.4%, while the Medical Equipment industry saw earnings growing at 1.9% annually. Revenues have been declining at an average rate of 0.8% per year. COLTENE Holding's return on equity is 12.3%, and it has net margins of 5.2%.

Key information

1.4%

Earnings growth rate

0.9%

EPS growth rate

Medical Equipment Industry Growth-9.5%
Revenue growth rate-0.8%
Return on equity12.3%
Net Margin5.2%
Next Earnings Update07 Mar 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How COLTENE Holding makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

LSE:0QP7 Revenue, expenses and earnings (CHF Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2423912970
31 Mar 2424112970
31 Dec 2324312970
30 Sep 2325318980
30 Jun 23264241000
31 Mar 23265251010
31 Dec 22267261020
30 Sep 22269261030
30 Jun 22271261030
31 Mar 22275291030
31 Dec 21279321020
30 Sep 21284291000
30 Jun 2128826970
31 Mar 2126817940
31 Dec 202488920
30 Sep 2024510980
30 Jun 20242121040
31 Mar 20258161080
31 Dec 19274201110
30 Sep 19264191060
30 Jun 19254191000
31 Mar 1922918910
31 Dec 1820417820
30 Sep 1819018770
30 Jun 1817619710
31 Mar 1817219700
31 Dec 1716819680
30 Sep 1716618670
30 Jun 1716316660
31 Mar 1716217660
31 Dec 1616117650
30 Sep 1615917640
30 Jun 1615717630
31 Mar 1615615630
31 Dec 1515513620
30 Sep 1515714640
30 Jun 1516014650
31 Mar 1516115650
31 Dec 1416216650
30 Sep 1416215600
30 Jun 1416114560
31 Mar 1416113570
31 Dec 1316013570

Quality Earnings: 0QP7 has high quality earnings.

Growing Profit Margin: 0QP7's current net profit margins (5.2%) are lower than last year (9.1%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 0QP7's earnings have grown by 1.4% per year over the past 5 years.

Accelerating Growth: 0QP7's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 0QP7 had negative earnings growth (-48.3%) over the past year, making it difficult to compare to the Medical Equipment industry average (39.9%).


Return on Equity

High ROE: 0QP7's Return on Equity (12.3%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 10:28
End of Day Share Price 2024/12/17 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

COLTENE Holding AG is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Martin WuermliBerenberg
Christoph GretlerCredit Suisse
Daniel JelovcanHelvea SA